Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Consulting Designing Pediatric Analgesic Treatment Regimens and Assessing Their Outcomes By Scott Millard July 26, 2017 Consulting Brexit: Bust or Boon for the Clinical Trials Industry? By Colin Hayward July 21, 2017 Data Management & Biostatistics Endpoint Data Capture Strategy: 4 Questions for Sponsors By Premier Research July 19, 2017 Clinical ResearchPhase 1 - Phase 4 Six Insights To Treating Fibromyalgia By Scott Millard July 14, 2017 Clinical ResearchPhase 1 - Phase 4 The Pathogenesis of Acne and What It Means for Drug Developers By Premier Research July 13, 2017 Clinical ResearchPhase 1 - Phase 4 Target Product Profiles: Turning Discoveries into Companies By Premier Research July 12, 2017 Previous 1 …42 43 44 45 46 … 56 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today